Episode 128: Debate of the Decade: RCTs in the Era of Precision Oncology
Healthcare Unfiltered
00:00
The Dangers of Using Real World Data to Assess Treatment Effectiveness
Ray: RCT could be a lot that too biased, frankly. You're really enrolling the fittest of the fit into these trials. He says using real world data to assess treatment effectiveness is no better than a coin flip about whether we'll give you the right answer. "There are numerous, numerous methodologic pitfalls," Ray adds.
Play episode from 01:15:49
Transcript
